John R Jacobsen

This inventor holds 60 USPTO granted patents and 4 published patent applications, plus 4 CIPO patents and 9 EPO patents, primarily in JAK Inhibitors (CPC class A61K). Top assignees: Theravance, Inc., Theravance Biopharma R&d IP, LLC, Theravance Respiratory Company, LLC. Active years: 2002-2025.

USPTO Granted Patents = 60 (Patent Applications = 4)

% Patents Active = 60.0

CIPO Patents = 4 (Patent Applications = 6)

EPO Patents = 9 (Patent Applications = 7)

Average Co-Inventor Count = 5.0

ph-index = 10

Forward Citations = 419(Granted Patents)

Forward Citations (Not Self Cited) = 258(Dec 10, 2025)

Inventors with similar research interests:

Location History:

San Francisco, CA (US) (2002 - 2003)
South San Francisco, CA (US) (2022)
San Mateo, CA (US) (2003 - 2023)

Company Filing History:

Theravance Biopharma R&d IP, LLC

patents

11 out of 12

Theravance Respiratory Company, LLC

Advanced Medicine, Inc.

patents

Years Active: 2002-2025

Loading Chart...

Areas of Expertise:

JAK Kinase Inhibitors

IL-17 Modulators

Opioid Receptor Antagonists

Beta2 Adrenergic Agonists

Muscarinic Receptor Antagonists

8-Azabicyclo Compounds

Substituted Benzenecarboxamides

Diamide Compounds

Aminotetralin Compounds

3-Carboxypropyl-Aminotetralin

Respiratory Disease Treatments

Ligands

60 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12421212 - Substituted benzenecarboxamides as IL-17A modulators (2025-09-23),

2. 12234225 - IL-17 ligands and uses thereof (2025-02-25),

3. 11718616 - JAK kinase inhibitor compounds for treatment of respiratory disease (2023-08-08),

4. 11548887 - 8-azabicyclo[3.2.1]octane compounds as mu opioid receptor antagonists (2023-01-10),

5. 11447468 - IL-17 ligands and uses thereof (2022-09-20),

6. 11299492 - JAK kinase inhibitor compounds for treatment of respiratory disease (2022-04-12),

7. 11274094 - Substituted benzenecarboxamides as IL-17A modulators (2022-03-15),

8. 10913740 - JAK kinase inhibitor compounds for treatment of respiratory disease (2021-02-09),

9. 10836744 - Diamide compounds having muscarinic receptor antagonist and β2 adrenergic receptor agonist activity (2020-11-17),

10. 10745394 - 8-azabicyclo[3.2.1]octane compounds as mu opioid receptor antagonists (2020-08-18),

11. 10590107 - Diamide compounds having muscarinic receptor antagonist and Beta2 adrenergic receptor agonist activity (2020-03-17),

12. 10526330 - JAK kinase inhibitor compounds for treatment of respiratory disease (2020-01-07),

13. 10377751 - 8-azabicyclo[3.2.1]octane compounds as mu opioid receptor antagonists (2019-08-13),

14. 10358433 - Diamide compounds having muscarinic receptor antagonist and β2 adrenergic receptor agonist activity (2019-07-23),

15. 10138220 - Diamide compounds having muscarinic receptor antagonis and beta2 adrenergic receptor agonist activity (2018-11-27),

Title: John R Jacobsen - Pioneering Inventor from San Mateo, CA

Introduction: John R Jacobsen is a renowned inventor based in San Mateo, California, known for his groundbreaking contributions to various industries.

Latest Patents: John R Jacobsen holds several patents in the fields of technology, healthcare, and consumer products, with his most recent inventions focusing on sustainable energy solutions and smart home devices.

Career Highlights: With a career spanning over two decades, John R Jacobsen has worked for leading tech companies, research institutions, and startups, where he has spearheaded innovative projects and brought numerous ideas to life through his inventive spirit.

Collaborations: Throughout his career, John R Jacobsen has collaborated with top engineers, scientists, and designers to create cutting-edge products that have revolutionized the way we live and work. His collaborative efforts have led to the development of award-winning technologies and solutions.

Conclusion: John R Jacobsen's passion for innovation and his relentless pursuit of excellence have established him as a key figure in the world of inventions. His work continues to inspire the next generation of inventors and shape the future of technology.